BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24607909)

  • 1. Tumor associated osteoclast-like giant cells promote tumor growth and lymphangiogenesis by secreting vascular endothelial growth factor-C.
    Hatano Y; Nakahama K; Isobe M; Morita I
    Biochem Biophys Res Commun; 2014 Mar; 446(1):149-54. PubMed ID: 24607909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoclast-like giant cells in invasive breast cancer predominantly possess M2-macrophage phenotype.
    Ohashi R; Yanagihara K; Namimatsu S; Sakatani T; Takei H; Naito Z; Shimizu A
    Pathol Res Pract; 2018 Feb; 214(2):253-258. PubMed ID: 29129494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of osteoclast differentiation by fibroblast growth factor 2: stimulation of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor expression in osteoblasts and inhibition of macrophage colony-stimulating factor function in osteoclast precursors.
    Chikazu D; Katagiri M; Ogasawara T; Ogata N; Shimoaka T; Takato T; Nakamura K; Kawaguchi H
    J Bone Miner Res; 2001 Nov; 16(11):2074-81. PubMed ID: 11697804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptotic osteocytes regulate osteoclast precursor recruitment and differentiation in vitro.
    Al-Dujaili SA; Lau E; Al-Dujaili H; Tsang K; Guenther A; You L
    J Cell Biochem; 2011 Sep; 112(9):2412-23. PubMed ID: 21538477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors.
    Itoh K; Udagawa N; Matsuzaki K; Takami M; Amano H; Shinki T; Ueno Y; Takahashi N; Suda T
    J Bone Miner Res; 2000 Sep; 15(9):1766-75. PubMed ID: 10976996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of pulmonary adenocarcinoma harboring osteoclast-like giant cells: Its evaluation by immunohistochemical and genetic analyses.
    Saito R; Fujishima F; Nakamura Y; Hoshikawa Y; Tominaga J; Taniuchi S; Kasajima A; Watanabe M; Okada Y; Sasano H
    Pathol Int; 2016 Apr; 66(4):224-9. PubMed ID: 26939759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer increases osteoclastogenesis by secreting M-CSF and upregulating RANKL in stromal cells.
    Mancino AT; Klimberg VS; Yamamoto M; Manolagas SC; Abe E
    J Surg Res; 2001 Sep; 100(1):18-24. PubMed ID: 11516200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia-inducible factor is expressed in giant cell tumour of bone and mediates paracrine effects of hypoxia on monocyte-osteoclast differentiation via induction of VEGF.
    Knowles HJ; Athanasou NA
    J Pathol; 2008 May; 215(1):56-66. PubMed ID: 18283716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.
    Quinn JM; Horwood NJ; Elliott J; Gillespie MT; Martin TJ
    J Bone Miner Res; 2000 Aug; 15(8):1459-66. PubMed ID: 10934644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells.
    Fujisaki K; Tanabe N; Suzuki N; Kawato T; Takeichi O; Tsuzukibashi O; Makimura M; Ito K; Maeno M
    Life Sci; 2007 Mar; 80(14):1311-8. PubMed ID: 17306833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-associated macrophages induce lymphangiogenesis in cervical cancer via interaction with tumor cells.
    Ding H; Cai J; Mao M; Fang Y; Huang Z; Jia J; Li T; Xu L; Wang J; Zhou J; Yang Q; Wang Z
    APMIS; 2014 Nov; 122(11):1059-69. PubMed ID: 24698523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spindle-shaped cells derived from giant-cell tumor of bone support differentiation of blood monocytes to osteoclast-like cells.
    Miyamoto N; Higuchi Y; Tajima M; Ito M; Tsurudome M; Nishio M; Kawano M; Sudo A; Uchida A; Ito Y
    J Orthop Res; 2000 Jul; 18(4):647-54. PubMed ID: 11052502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canonical and non-canonical pathways of osteoclast formation.
    Knowles HJ; Athanasou NA
    Histol Histopathol; 2009 Mar; 24(3):337-46. PubMed ID: 19130404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fos plays an essential role in the upregulation of RANK expression in osteoclast precursors within the bone microenvironment.
    Arai A; Mizoguchi T; Harada S; Kobayashi Y; Nakamichi Y; Yasuda H; Penninger JM; Yamada K; Udagawa N; Takahashi N
    J Cell Sci; 2012 Jun; 125(Pt 12):2910-7. PubMed ID: 22454522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor C stimulates progression of human gastric cancer via both autocrine and paracrine mechanisms.
    Kodama M; Kitadai Y; Tanaka M; Kuwai T; Tanaka S; Oue N; Yasui W; Chayama K
    Clin Cancer Res; 2008 Nov; 14(22):7205-14. PubMed ID: 19010837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
    Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
    Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis.
    Wong SY; Haack H; Crowley D; Barry M; Bronson RT; Hynes RO
    Cancer Res; 2005 Nov; 65(21):9789-98. PubMed ID: 16267000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoclast formation and function in pigmented villonodular synovitis.
    Taylor R; Kashima TG; Knowles H; Gibbons CL; Whitwell D; Athanasou NA
    J Pathol; 2011 Sep; 225(1):151-6. PubMed ID: 21706481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
    Valverde P; Tu Q; Chen J
    J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen regulates the production of VEGF for osteoclast formation and activity in op/op mice.
    Kodama I; Niida S; Sanada M; Yoshiko Y; Tsuda M; Maeda N; Ohama K
    J Bone Miner Res; 2004 Feb; 19(2):200-6. PubMed ID: 14969389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.